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a b s t r a c t
The attitudes towards the reuse for research of biological samples that were gathered in a diagnostics
context have changed over the last years. A few decades ago, people would not hesitate to use such
samples without explicit consent. Then, in conjunction with a move towards a stress to personal
autonomy in bioethics, many would argue that written consent for such secondary use is necessary. Not
much is known about the actual practices with regard to this subject. We have interviewed spokes-
persons of all eight Belgian centers for medical genetics, and have found that they would all adhere to the
latter stream of thought. As such, they would not use diagnostic DNA for research purposes without
written consent. Recently, however, international guidelines have moved towards the concept of
presumed consent for diagnostic samples. There is agreement that patients and donors should be
informed about possible research uses, and should be given the opportunity to opt out, but there is no
need for explicitly written consent to be able to use these samples. Extracted DNA may fall under the
same regime as other tissue that is gathered in a diagnostic or surgical context in university hospitals.
Such policy satisfies both the requirement of respect for donor’s autonomy as well as the requirement of
using research resources sensibly and is backed by international guidelines and opinions.
 2010 Elsevier Masson SAS. All rights reserved.
1. Introduction
Biological samples and extracted DNA gathered in the context of
diagnosis or in the context of studies for specific diseases can be
useful for research purposes, e.g. for large database studies [7,8].
Centers for medical genetics worldwide store huge collections of
extracted DNA gathered in the context of diagnostics and genetic
testing. There is much uncertainty, however, under which
circumstances these diagnostic collections could be used for
fundamental research, andwhether theywould fall under the same
regime as the general policy of the associated hospital with regard
to tissue samples and leftover bodily material. Most of this uncer-
tainty has to do with the type of consent that should exist for the
use of DNA samples for research and whether consent is truly
needed. The attitudes towards the reuse for research of biological
samples that were gathered in a diagnostics context have changed
over the last years. A few decades ago, people would not hesitate to
use such samples without explicit consent. Then, in conjunction
with a move towards stressing the importance of personal
autonomy in bioethics, many would argue that written consent for
such secondary use is necessary [6,11].
An example of the arguments for and against requiring consent
for the use of archived samples, originally gathered during diag-
nostics procedures or therapeutic surgical procedures can be found
in Van Diest and Savulescu’s debate ‘No consent should be needed
for using leftover body material for scientific purposes. For and
against’ [6]. Paul Van Diest, who thinks consent is not strictly
needed, remarks that consent is implicit in the consent obtained
from patients for the diagnosis and treatment of their disease. Such
material is kept in the benefit of the patient: new DNA tests are
constantly being developed and may shed new light on the genetic
condition the patient suffers from. But such collections are also
a rich source of teaching and research materials. He thinks that
recontacting patients for informed consent for research would take
too much time and money, whereas the research itself might ulti-
mately benefit patients as well. According to Van Diest, all issues
raised why such tissues should not be used can be easily solved:
researchers should make sure enough DNA is left for future
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diagnosis and coded or anonymous samples should be used for
research. It is also only fair that people are told that their tissues
might also be used for research, but this need not be in the form of
formal consent.
Julian Savulescu [6], however, thinks consent is needed to use
leftover tissue for research. He states that research on tissue can
harm patients by disclosing health or other information resulting in
discrimination in employment or insurance, that patients may have
values regarding research, especially commercial or genetic
research and that seeking consent promotes public confidence in
medicine and research, prevents exploitation, and regulates the
behavior of researchers.
We found no studies investigating the consent practices of
institutions storing DNA samples for diagnostic purposes. There-
fore, we investigated these practices in all the Belgian Centers for
Medical Genetics (CMG’s). We interviewed representatives of the
eight centers on the topics of the nature of their collections, and
consent practices for the use for research of tissue that was origi-
nally gathered in a research context. As most literature on the topic
of stored tissue samples deals with large population based studies,
our study is unique. First, it queries the practices in an entire
country. Secondly, the specific context, that of centers where
diagnostics and research are closely interwoven and legally regu-
lated, such as is the case in Belgium, can shed a unique light on the
matter. Hence, our purpose is twofold. We first give an overview of
the working and general practices of the Belgian Centers for
Medical Genetics to set the scene. Secondly, we discuss the prac-
tices with regard to the use of DNA in diagnostics collections for
research, and the perceived barriers to doing so.
Belgium has eight centers for human genetics, which are
recognized as per the royal decree of 14 December 1987 (Table 1).
This royal decree defines a center for human genetics as follows: A
center for human genetics is a center that does diagnosis on the
inheritability of certain malformations and abnormalities, mental
as well as physical, on the nature of these malformations and
abnormalities and on the carrier status of genetic characteristics.
Only centers that are recognized by the Minister of Public Health
are allowed to operate. Such recognition is dependent on certain
conditions. For example, the center should be dependent on
a university hospital with a faculty of medicine, only one center for
human genetics per university hospital is allowed, and the center is
led by a medical doctor with a specific education. At least two full
time medical doctors should be employed by the center. The center
should be able to supply a diagnosis or help in finding a diagnosis
and should give all possible psychological and moral assistance to
those concerned. They should also perform genetic research and
collect data for epidemiological purposes. The Institut de Patholo-
gie et de Génétique (IPG) is the only center not directly associated
with a university hospital. The royal decree specifies that centers
that were subsidized before 1st of January 1988 could also apply for
recognition even if they do not completely meet the above quoted
exceptions. The IPG is the sole example of this exception.
2. Material and methods
We conducted semi-structured interviews with spokespersons
of the eight centers for medical genetics in Belgium from January
2009 till July 2009. The interviewees consisted of five clinical
geneticists and three geneticists with laboratory responsibility.
Representatives were contacted by sending out an email with the
interview guide to the head of the center of medical genetics, who
would then do the interview him or herself or appoint someone to
do the interview. Each interview took between 40 min and 1 h30.
The language of the interviews was either French or Dutch,
depending on the mother tongue of the interviewee.
We developed an interview guide, containing questions about
the profile of the institute and the collection and consent proce-
dures (Table 2). This interview guide was reviewed by four
members of the Leuven Center for Human Genetics and revised
based on their suggestions. Our approach was a semi-structured
interview rather than a structured one as we wanted to pick in on
interesting remarks and finding during the interview. Kristien Hens
(KH) was the interviewer in all eight cases; Kris Dierickx (KD) was
assistant interviewer at the first interview.
Audiotapes of the sessions were transcribed but not corrected
for grammar, in order to capture the oral nature of the discussion.
We used NVivo 8 to code the transcripts [1]. First, the texts were
coded in eight cases, reflecting the different centers. Then we did
a detailed topical coding. We then combined the codes into broader
thematic categories. KH did an extra coding on paper to fully grasp
the themes of the interviews. As a last pass, we did a fresh coding to
grasp common themes across the different topics. The texts were
also checked for common themes independently by KH and KD. A
few quotes are included as examples; these were translated from
either Dutch or French in English. We interviewed six women and
two men. Throughout this paper we shall use the pronoun ‘she’
when referring to the interviewee.
3. Results
In this section we discuss the findings based on our eight semi-
structured interviews. We shall first discuss the types and profile of
the collections in the different institutions. Next we shall discuss
the issue of reusing collections for research and consent to such
research (Table 3).
4. Profile of the institute and the collection
The total number of staff members working at the different
CMG’s varies between 40 and 150. Three centers quoted the
number of 80 staff members. The centers had between 3 and 7
clinical geneticists. Most of the people in the center would combine
a clinical function and a research function, with the former as the
main task.
With regard to the types of collections, the vast majority of DNA
stored in the CMG’s is stored for diagnostic purposes. All centers
keep extracted DNA and cell lines; the original tissues are not
Table 1
University/Name of institution Language Address
Vrije Universiteit Brussel Dutch UZ VUB
Laarbeeklaan 103
1090 Jette
Katholieke Universiteit Leuven Dutch Campus Gasthuisberg
Herestraat 49
3000 Leuven
Universiteit Antwerpen Dutch Prins Boudewijnlaan 43
2650 Edegem
Universiteit Gent Dutch UZ Gent
De Pintelaan 185
9000 Gent
Université de Liège French Sart Tilman
Bâtiment B 35
4000 Liège
Université Libre de Bruxelles French Campus Erasme
Route de Lennik 808
1070 Bruxelles
Université Catholique de Louvain French Cliniques Universitaires St-Luc
Avenue Hippocrate 10
1020 Bruxelles
Institut de Pathologie et de
Génétique
French 25, Avenue George Lemaître
6041 Gosselies
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stored. They typically do not have big research collections. The
research collections that were mentioned were disease-specific
collections linked to special research interests of the clinical
geneticists. For example, one center had a biobank for research on
obesity with biological materials from healthy children. Another
center was setting up a database with healthy controls with the
help of an occupational health officer and was planning to set up
a cohort for positive controls as well. The representative of one
center was very clear on the fact that she did not consider the
diagnostics collection as a real bank, and hence, regulations con-
cerning biobanks would not apply. A representative of another
center stressed the fact that the diagnostics and research collec-
tions were completely separate, the latter containing volunteers
that had given written informed consent. Overall, diagnostics and
research were kept separate in all centers, although they may or
may not be physically managed in the same location.
The funding of the storing and managing of DNA collections at
the Belgian CMG’s was done through the consultations at the
hospital and was hence not limited in time. Two centers mentioned
the (limited in time) funding of specific research projects through
funding bodies such as the FWO (Research Foundation Flanders),
but one representative stated that such limited funding was typi-
cally not sufficient to accommodate for DNA storage. Additional
research projects linkedwith the CMG’s are hence primarily funded
through the cash flow from the hospitals.
All centers store links between family members, especially in
a diagnostics context. In this respect, one center mentioned that
their software would allow for extensive searches in family trees. If
samples are gathered for research purposes only, this is not always
done, if it is not relevant to the research. With regard to other
additional data, for the diagnostics collections, amedical file is kept,
but environmental and lifestyle data that are not relevant for
diagnosis are not kept systematically. If a research project requires
such additional information, however, it is possible that the
researcher gathers this kind of information.
A most controversial issue was the length of storage of DNA
samples. All centers had kept their DNA samples for diagnosis since
the beginning of extraction, al least 20 years ago. Four interviewees
stated that they did so because they were unsure whether they
were actually legally allowed to throw anything away. One inter-
viewee said it would be toomuch work to check which ones should
be destroyed and which ones kept, and therefore they were kept as
long as space permits.
One representative, a clinical geneticist, stated the clash
between practicality and potential clinical relevance as follows:
In principle you have to keep that DNA of course forever.
Sooner or later there has to be a limit because we shall have lack
of space. But I think it is also unethical if you have thatmaterial
to throw it away. Especially with genetic tests, these are family
histories. Let us say you have material that was stored in 1968,
from uncle X, who has a genetic disease. And now the great-
niece wants to inform about the likelihood of passing the risk to
her children. If you no longer have the material of the uncle, you
cannot check that, because he could be deceased. And that, I
think, is extremely unethical.
In the same context, another interviewee stated that it is all the
more important to keep materials from deceased persons. They
might have died from a genetic conditionwhich was untraceable at
the time of death, but for which a genetic test could have been
devised in the mean time. Information from that person’s DNA
could be relevant to family members. Moreover, the centers
acknowledge that they often had no way of knowing that a patient
whose DNA is in the collection had died.
5. Reuse of existing DNA collections and consent
The Belgian Centers for Medical Genetics primarily store DNA
for diagnostic purposes. The primary aim of most of the collections
is for the benefit of the patients who donated the DNA. Some of
these diagnostic uses may be on the boundary of research: if there
was no test available for a genetic condition when a sample was
taken, these samples could be used to validate new tests when they
become available. Hence, such research serves a diagnostic purpose
as well.
No explicit written consent is asked for storage of DNA samples
for diagnostic purposes. One clinical geneticist mentioned that
people are told that DNA is kept, and that people always regard this
as a reassurance, as it could be useful for their children or family
members. She made a comparison with RX pictures that are taken
for diagnostic purposes:
Table 3
Themes.
Themes
Profile of institution Centers had between 40 and 150 collaborators.
Profile of collection Diagnostics and research collections were kept separate
All centers kept extracted DNA indefinitely, also DNA from deceased persons.
Reuse of diagnostic samples Written informed consent was not asked for storage of samples in a diagnostic context
Centers would not reuse diagnostic samples for research without written consent
Informed consent 7/8 used specific consent for research
1/8 had a standard informed consent form
All centers would agree to a request for withdrawal of a sample from their research and diagnostics collections.
Table 2
Summary of questionnaire.
Themes Questions
Profile of institution How many people are working at your institution? How many are clinical geneticists? How many are researchers?
Profile of collection Which types of biological materials are stored? Do you have collections solely used for research?
How long do you store biological samples?Do you keep samples of deceased persons?
Do you keep links between family members? How is the
storage of biological materials funded?
Reuse of diagnostic samples Would you reuse samples gathered in a diagnostics context for
research purposes?
Informed consent Do you ask for written informed consent for storage of biological samples? Do you ask for specific consent or for
general consent? Do donors or patients have the right to withdraw their sample from the collection?
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An oral [consent], especially because it is for clinical purposes.
You can compare it to an RX picture that was taken from you,
you assume that they keep it but you do not give written
consent for the fact that they keep those images.
The collection of samples that was kept for diagnostic purposes
was not used for research purposes without written consent. Only
one representative thought that in case of completely anonymized
samples, that were separated from the diagnostics collection, they
would maybe consider having research on these samples approved
by the hospital’s ethics committee, but she was uncertain whether
this had already happened. Two other representatives were explicit
that their ethics committee would not allow research on samples
for which there was not explicit written consent for that research.
All interviewees thought that, should part of the collection prove to
be very interesting for research, they would try to recontact the
patients via the clinical geneticist who sees the patient for written
consent. Or, when they would know beforehand that a sample of
a patient would be particularly interesting for research, the clinical
geneticist would solicit written consent at the time of the genetic
consultation. One clinical geneticist we interviewed expressed this
as follows:
In any case, our ethics committee is very vigilant: storage of DNA
[in case of research] is generally done in the context of
a research project with an ethics committee approval. Our ethics
committee does not really like that we would stock for future
unspecified research, it has to be done with a specific aim. If we
would want to use our collection for other reasons we should
have foreseen it in a formal consent beforehand, but it is a bit
difficult to say we shall probably do something else. Therefore
our ethics committee does not like it. In any case we should
contact the people that have accepted to give us their DNA.
The consent forms themselves were mostly created or adapted
individually for each research study, although some representatives
mentioned that theywere in the process of creating amore standard
form for the entire center, and one already had a standard consent
form that is used by all clinical geneticists of the center. This consent
form is analyzed inTable4. Consentwasgiven for researchon specific
conditions, although one center used general consent for unspecified
research for their collection of control samples.
With regard to the right to withdraw DNA from a collection,
research or diagnostics, all representatives agreed that they would
comply with a request of withdrawal. This however did not happen
often, and most thought the situation to be quite hypothetical, as,
especially in a diagnostic context, something that may be useful for
a patient would be gone. Only two interviewees could remember
a casewere thiswas requested. One clinical geneticist stated that the
opposite situationwas more prevalent: she had cases where people
insist on DNA being kept even if they did not have a diagnostic test
themselves, so that their children would still have access to that
information once they themselves were deceased. Seven centers
stated that they would destroy the sample when asked. One person
remarked that in theone case theyhada request forwithdrawal they
decided to keep the sample but just not to use it any further. The
reason for thiswas that if a sample is destroyed, diagnostic tests that
were already done on it could no longer be validated.
6. Discussion
The eight Belgian Centers for Medical Genetics are primarily
diagnostic institutes, with some research activities. As diagnostic
centers, they have large collections of DNA samples, which, in
principle, could also form a rich resource for research. However, our
interviewees were reluctant to use the diagnostics collections for
research. Themain barrier quoted that therewas no explicit written
consent from the donors. Additionally, some stated that their ethics
committee would never allow such research without such consent.
Research was in this context understood by them as non-thera-
peutic research, having no direct benefit for the participants.
However, in the specific context of these centers, the boundary
between research and diagnostics seems to be often blurred. The
storage of DNA serves both a diagnostics and research purpose that
cannot easily be separated in certain cases. For example, stored
DNA may be used to develop new diagnostic tests. Anecdotic
evidence shows that in such cases, consent is not always sought
from the donor, because such findings may still benefit the patient.
Hence, the consent requirement seems in some instances to be
linked to the benefit factor of research. The reluctance to reuse
diagnostic samples for research was also linked to an uncertainty
about the legal requirements, as we find also on other topics in this
context, such as carrier testing on minors [2]. Also the overall
tendency to keep samples forever is linked to this. This calls for
clear legal guidance from the legislator’s side and for a need to
educate researchers and clinicians on the legal aspects.
For more general non-therapeutic research purposes, there
seems to be a trend away from requiring explicit consent for research
using existing collections of human tissue in literature and guide-
lines. Some authors have suggested frameworks thatwould allow for
such research without consent [6]. Gert Helgesson, for example, has
created an ethical framework for research on ‘consentless’ samples
in clinical biobanks. He proposes that each research project should
be preceded by a careful assessment by both the researchers
themselves and an ethical review board (ERB) to ascertain predict-
able risks and burdens in relation to foreseeable benefits to the
subject and others. He has developed consent routines for research
on biobank samples where no consent was obtained or the consent
was unclear, and thinks that, given proper ethical guidance, such
samplesmay be usedwithout new consent, under an opt-out regime
[9]. He also thinks that deceased subjects may be included, because
excluding them would create bias, except if the donor or his or her
survivors explicitly requests the material is not used. Also Bathe and
McGuire have a similar stance. They acknowledge the fact that
archival tissue is a rich source for translational research and that
recontacting donors may be unfeasible or unpractical. They think
Table 4
Analysis of one standardized consent form for research on and storage of DNA samples.
Themes Elaboration
Type of consent form Written consent
Scope of consent form Taking of DNA sample for research and storage
Scope of research Genetic research that can aid the diagnosis or treatment of the illness of the patient or a family member
Information for patient Doctor has mentioned techniques; the fact that the study takes several years, that the DNA is stored, and which results such
research might have.
Medical data and confidentiality Data from medical file can be used. Mentions confidentiality. Does not mention identifiability of samples. Only the named
doctor or someone authorized by this doctor can access the information.
Right to withdraw Patient has right to ask for the destruction of DNA
Return of results Donor specifies whether they want to receive the results of the study. Nu further specification about the type of results.
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that, when an ethics committee has assessed the purpose of the
research, and that privacy concerns are addressed through proper
coding, the requirement for informed consent could be waved [3].
Some empirical studies have pointed in this direction aswell. For
example, A study by Stegmayr has shown that is not unfeasible to
recontact donors and the vast majority (93,0%) would agree to give
their blood samples for academic genetic research provided that an
ethics committee had approved of the research. A majority of that
was OK with general consent, 22% wanted to be informed of each
research project [13]. This strategy would also agree with findings
from a focus group study amongst the Belgian population [10].
In a review of international and national guidelines on the
secondary use of archived biological samples, that were gathered
for diagnosis or other research, Bartha Maria Knoppers found that
many policymakers make a difference regarding the identifiability
of samples, whether they are anonymized or not. They also reflect
a move away from requiring an explicit reconsent for all secondary
uses, provided other safeguards are in place, such as double-coding,
anonymization and Research Ethics Board (REB) approval [11]. Also
the Human Genome Project states that stored samples can be used
if there is a general notification of such policy, the participant has
not objected and the samples are coded or anonymized afterwards
[5]. In the recent guidelines of the OECD on Human Biobanks and
Genetic Research Databases [12], the possibility of a waiver of
consent for existing collections is mentioned, when law permits
and after review of an ethics committee:
In the situations ofHBGRDs established fromexisting collections,
the operators will need to consider whether the intended scope
and purpose of the HBGRD and the intended research uses of the
human biological materials and/or data are consistent with the
original informed consent. Where the intended scope of
the HBGRD or its intended uses are not within the ambit of the
original informed consentor nonewasobtained, for example, the
humanbiologicalmaterials and/ordatamayonly beused if a new
consent is obtained or if a waiver of consent is obtained from
a research ethics committee or an appropriate authority, in
accordance with applicable law and ethical principles.
On a European level, in the Recommendation of the Committee
of Ministers tomember states on research on biological materials of
human origin [4] there are also provisions for the reuse of material
for research.
1. Biological materials removed for purposes other than storage
for research should only be made available for research activ-
ities with appropriate consent or authorization, or in accor-
dance with the provisions of Article 22 paragraph 1.ii. Art 22.
1.i. If the proposed use of identifiable biological materials in
a research project is not within the scope of prior consent, if
any, given by the person concerned, reasonable efforts
should be made to contact the person in order to obtain
consent to the proposed use.
ii. If contacting the person concerned is not possible with
reasonable efforts, these biological materials should only be
used in the research project subject to independent evalua-
tion of the fulfilment of the following conditions:
a. the research addresses an important scientific interest;
b. the aims of the research could not reasonably be achieved
using biological materials for which consent can be
obtained; and
c. there is no evidence that the person concerned has
expressly opposed such research use.
This recommendation suggest that, for research projects that
have been reviewed by ERBs and given proper governance and
privacy protection of the collections themselves, diagnostics
collections of DNA could be used for research purposes as well.
Many hospitals nowadays use a notification policy for other types of
leftover tissue such as surgical waste. They distribute folders
explaining the fact that such tissue may be reused for research.
Below is an example from the folder of one such hospital, which is
given to patients upon admittance:
Analysis of bodily material
Bodily material that is left over after a diagnosis or surgery
(leftover material) may be used for scientific research. Each such
research should be preceded by a positive recommendation
from the ethics committee of Hospital X. If you do not wish this
to happen, you or your representative can refuse such use. You
can discuss your refusal with the clinician responsible for
removing the bodilymaterial or with the chief of medical staff of
Hospital X. (translated from Dutch).
Extracted DNA stored in centers for human genetics associated
with these hospitals could fall under the same regime, although the
perceived special status of DNA could form a barrier to the accep-
tance of such policy. For new samples the potential research use of
samples can be discussed by the clinical geneticist when blood is
taken. We think that such an approach would both be respectful for
the donor as well as allow research to proceed, especially if it is
accompanied with the right to withdraw samples at any time and
provided participants and patients have the opportunity to be
informed about the types of research performed at the hospital, if
they do so wish.
The majority of our interviewees specified that they ask for
specific consent for research. However, empirical research amongst
donors has shown that many people do not mind giving broad
consent [15]. And a recent study has shown that a majority would
be willing to consider giving open ended consent for the use of
blood left over from routine clinical tests in general practice to be
stored and used later for medical research [14]. If research would
take a turn away from the original condition or conditions the
patient suffers from, or if the nature of research would change
drastically (e.g. a complete genome sequence would be done), the
donor should probably be recontacted. Also the OECD guidelines
suggest that a relatively broader consent can be devised, provided
that the participant understand and consent to participating on this
broader basis; and (b) additional safeguards are in place to ensure
that the interests of the participant are protected. So, Ethics
committees could be educated not to be too conservative on the
one hand, and to be able to decide sensibly when research takes
a turn that would require recontacting donors for consent.
We admit that our study has several limitations. First, our
interviewees had different profiles, which means that they have
different perspectives on the practices in their institutions. Second,
as we used interviews rather than surveys, our data was not
completely quantifiable. Third, as the interviewer was an ethicist,
we can not be sure whether the answers given would be best
practices rather than real practices. However, our study has shown
that there is a strong ethical awareness amongst professionals
working with diagnostic samples, and an overemphasis on consent.
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